0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThe TESTING study (combined full and low dose) will define the benefits of corticosteroid use on major kidney outcomes, as well as the risks of therapy, and provide data on the relative effects of different doses, in individuals with high-risk IgAN.
Alan Cass, John Feehally, Jürgen Floege, Giuseppe Remuzzi, Yangfeng Wu, Rajiv Agarwal, Hong Zhang, Vlado Perkovic, Muh Geot Wong, Jicheng Lv, Michelle Hladunewich, Vivekanand Jha, Lai Seong Hooi, Helen Monaghan, Ming‐Hui Zhao, Sean Barbour, Heather N. Reich, Daniel C. Cattran, Richard J. Glassock, Adeera Levin, Meg Jardine, David C. Wheeler, Mark Woodward, Laurent Billot, Tak Mao Chan, Zhihong Liu, David W. Johnson (2021). The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics. , 52(10-11), DOI: https://doi.org/10.1159/000519812.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2021
Authors
27
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1159/000519812
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
.webp){kind=avatar}
